Log in
Enquire now
‌

US Patent 10336995 Beta-lactamases with improved properties for therapy

Patent 10336995 was granted and assigned to Synthetic Biologics, Inc. on July, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

This invention relates to, in part, compositions of beta-lactamases and methods of using these enzymes in, for example, gastrointestinal tract (GI tract) disorders such as C. difficile infection (CDI).

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10336995 Beta-lactamases with improved properties for therapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.